首页> 中文期刊> 《中国卫生政策研究》 >我国公立医院药品价格形成机制的演变及未来政策选择

我国公立医院药品价格形成机制的演变及未来政策选择

         

摘要

首先分析公立医院药品采购中的销售合同及采购合同,并指出两个合同中的"市场失灵".而政府定价、行政降价、顺加作价、集中招标采购等行政手段实施后,药品采购相关利益方采取各种博弈行为,公立医院药品采购和价格形成出现"政府失灵".未来的公立医院药品价格形成应该为政府有限调控下的市场定价,在保持集中招标采购和零差率两个行政手段的基础上,提高医疗保险机构的价格谈判和公立医院在招标过程中的参与度.%This paper firstly analyses the sales and purchase contracts in the procurement of drugs in public hospitals, and then points out the "market failure" in the two contracts. After the implementation of administrative measures such as government pricing, administrative price reduction, price increase, centralized bidding and purcha-sing, various drug procurement stakeholders have adopted various game behaviors, and government procurement and price formation have appeared in government hospitals, not-neglecting the formation of the price of"Government fail-ure". The future price formation in public hospitals should be the market pricing under the limited government regu-lation, and increase the medical insurance institutions' price negotiation and the public hospitals' participation degree in the bidding process based on maintaining the centralized bidding and purchasing and zero administrative rate.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号